An Exploratory, Pilot Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome: A Sub-study to the ZX008-1503 Open-Label Extension Trial
Phase of Trial: Phase III
Latest Information Update: 22 Jan 2019
At a glance
- Drugs Fenfluramine (Primary)
- Indications Dravet syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Zogenix
- 13 Jan 2019 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
- 13 Jan 2019 Planned primary completion date changed from 31 Dec 2018 to 1 Jan 2020.
- 16 Sep 2018 Planned End Date changed from 31 Dec 2018 to 1 Jan 2019.